Skip to content

MRC (UKRI)

Translation MRC Impact Acceleration Awards

£50k–£300k FEC (80% funded, i.e. up to £240k awarded)| Deadline: 11 November 2026 (115 days)|6–18 months

4:00pm UK time

Last verified:

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →

The MRC Translation Impact Acceleration Awards fund £50k-£300k (80% funded) for academically led translational research projects generating critical preliminary data to advance new medicines, devices, diagnostics, or medical interventions toward clinical development. Eligible applicants are researchers at UK institutions; international researchers may join as co-leads, but businesses and non-approved charities cannot be lead applicants. Projects run 6-18 months and exclude clinical trials and fundamental research.

Details

Funder MRC (UKRI)
Budget £50k–£300k FEC (80% funded, i.e. up to £240k awarded)
Deadline 11 November 2026
Duration 6–18 months
Consortium No
Application Single stage
Eligible countries GB

Eligibility & scope

Academically led translational single-step projects generating critical preliminary data for new medicines, devices, diagnostics or other medical interventions. UK research organisations eligible as lead; international researchers may join as project co-leads. Businesses and non-approved charities cannot lead. No clinical trials or fundamental research. Proposals must be submitted in English via UKRI Funding Service.

Who Should Apply

  • Researchers at UK academic institutions or approved research organisations
  • Translational teams with preliminary data ready to advance toward next development stage
  • Projects on new medicines, devices, diagnostics, or medical interventions (no fundamental research or clinical trials)
  • Teams willing to work with international co-leads, but lead organisation must be UK-based

Key Dates

  • Deadline: 11 November 2026, 4:00 PM UK time
  • Single-stage written evaluation
  • Project duration 6-18 months

Tips for Applicants

  • Lead with preliminary data and the critical gap it bridges, reviewers expect near-commercialisation readiness, not exploratory science.
  • Name a clear translational pathway (e.g. regulatory milestones, IP strategy, industry route); vague 'future development' language scores poorly.
  • International co-leads strengthen the proposal if they add specific technical or clinical depth; include a co-lead letter confirming their role and commitment.

Frequently Asked Questions

How much does the MRC Translation Impact Acceleration Award fund?

Up to £300,000 (80% funded, so up to £240,000 awarded); the funder covers 80% of Full Economic Cost.

What is the project duration for the MRC Translation Impact Acceleration Award?

Projects run between 6 and 18 months, depending on scope and the preliminary data package.

Can international researchers lead an MRC Translation Impact Acceleration Award?

No; the lead organisation must be a UK research institution. International researchers may participate as named project co-leads.

What types of research are ineligible for the MRC Translation Impact Acceleration Award?

Clinical trials, fundamental research, and proposals led by businesses or non-approved charities are not eligible.

When is the deadline for the MRC Translation Impact Acceleration Award?

The deadline is 11 November 2026 at 4:00 PM UK time; applications are submitted via the UKRI Funding Service.

mrctranslational-researchukriuk-basedimpact-accelerationmedicines-devices-diagnosticspreliminary-data

Related on Grantsby

Summary generated by AI based on published grant information. Always verify details on the funder's website.

More from MRC (UKRI)

Browse all open grants →

Browse Related

Could Translation MRC Impact Acceleration Awards be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →